Literature DB >> 28496075

Determination of Fasting and Non-Fasting Cholesterol Levels of Low- and High-Density Lipoproteins with Homogenous Assays: A Promising Reliable Way to Assessment of Dyslipidemia.

Hiroshi Yoshida1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28496075      PMCID: PMC5453682          DOI: 10.5551/jat.ED076

Source DB:  PubMed          Journal:  J Atheroscler Thromb        ISSN: 1340-3478            Impact factor:   4.928


× No keyword cloud information.
  23 in total

1.  Triglyceride concentrations should be measured after elimination of free glycerol to exclude interindividual variations due to adiposity and fasting status.

Authors:  Terumichi Nakagawa; Satoshi Hirayama; Toshiyuki Watanabe; Mamoru Yokomura; Masaomi Kohno; Taiki Sato; Hideaki Bujo; Asako Sato; Mitsuru Murata; Takashi Miida
Journal:  Clin Chem Lab Med       Date:  2017-08-28       Impact factor: 3.694

2.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

3.  Seven direct methods for measuring HDL and LDL cholesterol compared with ultracentrifugation reference measurement procedures.

Authors:  W Greg Miller; Gary L Myers; Ikunosuke Sakurabayashi; Lorin M Bachmann; Samuel P Caudill; Andrzej Dziekonski; Selvin Edwards; Mary M Kimberly; William J Korzun; Elizabeth T Leary; Katsuyuki Nakajima; Masakazu Nakamura; Göran Nilsson; Robert D Shamburek; George W Vetrovec; G Russell Warnick; Alan T Remaley
Journal:  Clin Chem       Date:  2010-04-08       Impact factor: 8.327

4.  Fasting Is Not Routinely Required for Determination of a Lipid Profile: Clinical and Laboratory Implications Including Flagging at Desirable Concentration Cutpoints-A Joint Consensus Statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine.

Authors:  Børge G Nordestgaard; Anne Langsted; Samia Mora; Genovefa Kolovou; Hannsjörg Baum; Eric Bruckert; Gerald F Watts; Grazyna Sypniewska; Olov Wiklund; Jan Borén; M John Chapman; Christa Cobbaert; Olivier S Descamps; Arnold von Eckardstein; Pia R Kamstrup; Kari Pulkki; Florian Kronenberg; Alan T Remaley; Nader Rifai; Emilio Ros; Michel Langlois
Journal:  Clin Chem       Date:  2016-05-27       Impact factor: 8.327

5.  Serum triglycerides and risk of coronary heart disease among Japanese men and women.

Authors:  H Iso; Y Naito; S Sato; A Kitamura; T Okamura; T Sankai; T Shimamoto; M Iida; Y Komachi
Journal:  Am J Epidemiol       Date:  2001-03-01       Impact factor: 4.897

6.  Identifying an Optimal Cutpoint for the Diagnosis of Hypertriglyceridemia in the Nonfasting State.

Authors:  Khendi T White; M V Moorthy; Akintunde O Akinkuolie; Olga Demler; Paul M Ridker; Nancy R Cook; Samia Mora
Journal:  Clin Chem       Date:  2015-06-12       Impact factor: 8.327

Review 7.  Triglyceride-Rich Lipoproteins and Atherosclerotic Cardiovascular Disease: New Insights From Epidemiology, Genetics, and Biology.

Authors:  Børge G Nordestgaard
Journal:  Circ Res       Date:  2016-02-19       Impact factor: 17.367

8.  High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study.

Authors:  T Gordon; W P Castelli; M C Hjortland; W B Kannel; T R Dawber
Journal:  Am J Med       Date:  1977-05       Impact factor: 4.965

9.  Relation of triglyceride levels, fasting and nonfasting, to fatal and nonfatal coronary heart disease.

Authors:  Lynn E Eberly; Jeremiah Stamler; James D Neaton
Journal:  Arch Intern Med       Date:  2003-05-12

Review 10.  Mendelian randomization studies in coronary artery disease.

Authors:  Henning Jansen; Nilesh J Samani; Heribert Schunkert
Journal:  Eur Heart J       Date:  2014-06-10       Impact factor: 29.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.